In June 2017, VentureFounders successfully supported Lein AD in its £440k equity raise, alongside angel investors and existing shareholders including NESTA, MTI and Seven Spires.
Lein Applied Diagnostics has developed an innovative, optical technology that makes high precision, non-contacting measurements on many organic and inorganic materials. Based around a scanning confocal system, Lein AD’s unique technology has applications in the medical and industrial sectors and has been proven to deliver high precision measurements in hostile and hard to reach environments.
Lein Applied Diagnostics is focusing on three major markets:
- High resolution metrology: the measurement of physical dimensions for medical and industrial markets
- Diabetes care: the non-invasive measurement of glucose for people with diabetes
- Pharmacokinetics: the-real time measurement of the diffusion of pharmaceutical drugs in the body